Peter Sanguinetti - Australian Pharmaceutical Insider

Australian Pharmaceutical Industries Limited -- Australia Stock  

AUD 1.46  0.04  2.82%

Chief Legal Counsel, Company Secretary

Mr. Peter F. Sanguinetti serves as General Counsel, Company Secretary of Australian Pharmaceutical Industries Ltd., since November 2007. Mr Sanguinetti BJuris, LLB, GAICD has extensive experience and was previously Company Secretary and General Counsel of Kodak Pty Ltd for 9 years, responsible for legal and company secretarial activities for the Kodak group across Asia. Mr Sanguinetti was also a nonexecutive director of HPAL Limited from January 2005 to November 2007. On 2 June 2009.
  Executive Since 2007      
61 3 8855 3000

Management Efficiency

The company has return on total asset (ROA) of 3.85 % which means that it generated profit of $3.85 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 9.6 % meaning that it generated $9.6 on every $100 dollars invested by stockholders.
The company has accumulated 32.6 M in total debt with debt to equity ratio (D/E) of 5.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Australian Pharmaceutical Industries Limited has Current Ratio of 1.29 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia. Australian Pharmaceutical operates under Medical Equipment Wholesale classification in Australia and traded on Australian Securities Exchange.Australian Pharmaceutical Industries Limited (API) is traded on Australian Securities Exchange in Australia. It is located in 250 Camberwell Road and employs 18 people.

Did you try this?

Run Watchlist Optimization Now

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Hide  View All  NextLaunch Watchlist Optimization

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Australian Pharmaceutical Industries Limited to your portfolio

Top Management

Australian Pharmaceutical Leadership Team

Stock Performance

Australian Pharmaceutical Performance Indicators